1752
N.A. Petasis, A.N. Butkevich / Journal of Organometallic Chemistry 694 (2009) 1747–1753
8.10 (d, J = 2.5 Hz, 1H). 13C NMR (100 MHz, CDCl3): d 39.2, 57.4,
121.8, 123.4, 124.6, 125.6, 127.0, 128.0, 128.5, 128.7, 129.7,
137.4, 138.9, 145.0.
up as described above in the general procedure. Rf values (ethyl
acetate:hexane 1:3): for compound 37 Rf = 0.4, for compound 45
Rf = 0.6; both stained grey upon heating with vanillin stain. The
products were isolated by column chromatography on silica (elu-
ent – ethyl acetate:hexane 1:9, changed to 1:5 after elution of
the compound 45), yielding 124 mg (26%) of 45 and 86 mg (30%)
of 37.
3.6.6. 2-(4-Chlorophenyl)-1-(methylsulfonyl)-1,2-dihydro-quinoline
(49a)
1H NMR (400 MHz, CDCl3): d 2.79 (s, 3H), 5.99 (d, J = 6.0 Hz, 1H),
6.31 (dd, J = 9.8 Hz, 6.0 Hz, 1H), 6.87 (d, J = 9.8 Hz, 1H), 7.21–7.33
(m, 7H), 7.54–7.59 (m, 1H). 13C NMR (100 MHz, CDCl3): d 37.8,
56.2, 126.6, 126.75, 126.79, 127.0, 127.9, 128.6, 128.7, 128.9,
132.6, 133.9, 136.6.
3.8. Synthesis of 2-phenylquinoline (50)
The solution of 285 mg (1 mmol) of compound 37 and 400 mg
(10 mmol) of NaOH in 10 mL of absolute ethanol was stirred at
50 °C for 12 h. The reaction mixture was then poured into 30 mL
of water, extracted with 3 Â 20 mL of ethyl acetate, and the com-
bined organic extracts were washed with 25 mL of water. The or-
ganic layer was dried over Na2SO4, filtered and evaporated to
give yellowish crystals of 2-phenylquinoline (50) (205 mg, >99%).
1H NMR (400 MHz, CDCl3): d 7.45–7.50 (m, 1H), 7.51–7.57 (m,
3H), 7.71–7.77 (m, 1H), 7.83 (d, J = 8.3 Hz, 1H), 7.88 (d, J = 8.3 Hz,
1H), 8.15–8.24 (m, 4H). 13C NMR (100 MHz, CDCl3): d 119.0,
126.2, 127.1, 127.4, 127.5, 128.8, 129.3, 129.6, 129.7, 136.7,
139.7, 148.3, 157.3.
3.6.7. 2-(4-Methoxyphenyl)-1-(methylsulfonyl)-1,2-dihydro-quinoline
(49b)
1H NMR (400 MHz, CDCl3): d 2.78 (s, 3H), 3.77 (s, 3H), 5.98 (d,
J = 5.8 Hz, 1H), 6.29 (dd, J = 9.6 Hz, 5.8 Hz, 1H), 6.80 (d, J = 8.7 Hz,
2H), 6.84 (d, J = 9.6 Hz, 1H), 7.20–7.30 (m, 5H), 7.52–7.56 (m,
1H). 13C NMR (100 MHz, CDCl3): d 37.8, 55.2, 56.6, 113.8, 126.1,
126.5, 126.6, 127.0, 127.5, 128.1, 128.6, 128.7, 129.9, 132.9, 159.4.
3.6.8. 1-(Methylsulfonyl)-2-[4-(trifluoromethyl)phenyl]-1,2-
dihydroquinoline (49c)
1H NMR (400 MHz, CDCl3): d 2.81 (s, 3H), 6.08 (d, J = 6.0 Hz, 1H),
6.37 (dd, J = 9.6 Hz, 6.0 Hz, 1H), 6.90 (d, J = 9.6 Hz, 1H), 7.22–7.31
(m, 3H), 7.48–7.57 (m, 4H), 7.61 (d, J = 7.5 Hz, 1H). 13C NMR
3.9. 1-(Methylsulfonyl)-2-phenyl-1,2,3,4-tetrahydroquino-line (51)
1
(100 MHz, CDCl3): d 37.8, 56.3, 121.2 (q, JC,F = 271 Hz), 125.4 (q,
To the solution of 285 mg (1 mmol) of compound 37 in 10 mL of
absolute ethanol 20 mg of 5% palladium on carbon was added un-
der nitrogen. The reaction mixture was stirred overnight at room
temperature under hydrogen (1 atm), filtered through a short plug
of silica gel and washed with 200 mL of ethyl acetate. The filtrate
was evaporated and dried in vacuo to yield 1-(methylsulfonyl)-2-
phenyl-1,2,3,4-tetrahydroquinoline (51) (290 mg, >99%) as viscous
colorless oil. 1H NMR (400 MHz, CDCl3): d 2.05–2.15 (m, 1H), 2.48–
2.57 (m, 1H), 2.64–2.81 (m, 2H), 2.89 (s, 3H), 5.61 (t, J = 6.8 Hz, 1H),
7.12–7.20 (m, 2H), 7.23–7.37 (m, 6H), 7.82 (d, J = 7.9 Hz, 1H). 13C
NMR (100 MHz, CDCl3): d 25.1, 31.4, 39.0, 59.0, 123.4, 124.5,
125.9, 126.9, 127.0, 128.4, 128.6, 131.4, 136.2, 141.7.
3JC,F = 4 Hz), 126.2, 126.88, 126.91, 126.98, 127.1, 127.6, 127.8,
2
129.0, 130.1 (q, JC,F = 32 Hz), 132.6, 142.3. 19F NMR (376 MHz,
CDCl3): d À62.59.
3.6.9. 2-Cyclohex-1-en-1-yl-1-(methylsulfonyl)-1,2-dihydro-quinoline
(49d)
1H NMR (400 MHz, CDCl3): d 1.35–1.62 (m, 4H), 1.74–1.95 (m,
3H), 2.09–2.20 (m, 1H), 5.15 (d, J = 5.6 Hz, 1H), 5.53–5.58 (m,
1H), 6.00 (dd, J = 9.5 Hz, 5.6 Hz, 1H), 6.64 (d, J = 9.5 Hz, 1H), 7.09–
7.23 (m, 3H), 7.53 (d, J = 7.9 Hz, 1H). 13C NMR (100 MHz, CDCl3):
d 21.9, 22.4, 24.9, 25.1, 37.3, 59.0, 125.4, 125.7, 126.2, 126.4,
126.7, 127.1, 128.1, 128.2, 133.2, 133.8.
Acknowledgements
3.6.10. 7-bromo-2-butyl-1-(methylsulfonyl)-1,2-dihydro-quinoline
(49e)
Financial support by the National Institutes of Health and the
Loker Hydrocarbon Research Institute of the University of Southern
California is gratefully acknowledged.
1H NMR (400 MHz, CDCl3): d 0.84 (t, J = 7.0 Hz, 1H), 1.17–1.47
(m, 6H), 2.66 (s, 3H), 4.65–4.73 (m, 1H), 6.11 (dd, J = 9.6 Hz,
5.8 Hz, 1H), 6.49 (d, J = 9.6 Hz, 1H), 7.01 (d, J = 8.3 Hz, 1H), 7.33
(dd, J = 8.3 Hz, 1.7 Hz, 1H), 7.77 (d, J = 1.7 Hz, 1H). 13C NMR
(100 MHz, CDCl3): d 13.9, 22.0, 27.2, 32.7, 37.8, 55.1, 121.2,
124.0, 127.0, 127.6, 129.7, 130.1, 130.2, 133.9.
References
[1] G.P. Ellis (Ed.), Chromenes, Chromanones, and Chromones, The Chemistry of
Heterocyclic Compounds, vol. 31, Wiley Interscience, New York, 1977.
[2] K.C. Nicolaou, J.A. Pfefferkorn, A.J. Roecker, G.Q. Cao, S. Barluenga, H.J. Mitchell,
J. Am. Chem. Soc. 122 (2000) 9939–9953.
[3] N.C. Veitch, R.J. Grayer, Nat. Product Rep. 25 (2008) 555–611.
[4] P.A. Wehrli, R.I. Fryer, W. Metlesics, J. Org. Chem. 36 (1971) 2910–2912.
[5] H.H. Hussain, G. Babic, T. Durst, J.S. Wright, M. Flueraru, A. Chichirau, L.L.
Chepelev, J. Org. Chem. 68 (2003) 7023–7032.
3.6.11. 7-Bromoquinoline (49f)
1H NMR (400 MHz, CDCl3): d 7.37–7.42 (m, 1H), 7.59–7.64 (m,
1H), 7.67 (d, J = 8.7 Hz, 1H), 8.08–8.13 (m, 1H), 8.26–8.29 (m,
1H), 8.88–8.91 (m, 1H). 13C NMR (100 MHz, CDCl3): d 121.4,
123.5, 126.8, 129.0, 130.1, 131.7, 135.9, 148.7, 151.2.
[6] B.M. Trost, F.D. Toste, J. Am. Chem. Soc. 120 (1998) 9074–9075.
[7] B.M. Trost, H.C. Shen, L. Dong, J.P. Surivet, C. Sylvain, J. Am. Chem. Soc. 126
(2004) 11966–11983.
3.7. Reaction of potassium 2-phenylvinyltrifluoroborate with N-(2-
formylphenyl)methanesulfonamide and dibenzylamine
[8] Y. Kokubo, A. Hasegawa, S. Kuwata, K. Ishihara, H. Yamamoto, T. Ikariya, Adv.
Synth. Catal. 347 (2005) 220–224.
[9] L.F. Tietze, K.M. Sommer, J. Zinngrebe, F. Stecker, Angew. Chem., Int. Ed. 44
(2005) 257–259.
[10] R. Chenevert, G. Courchesne, N. Pelchat, Bioorg. Med. Chem. 14 (2006) 5389–
5396.
[11] B.M. Trost, H.C. Shen, L. Dong, J.P. Surivet, J. Am. Chem. Soc. 125 (2003) 9276–
9277.
[12] M. Palucki, N. Yasuda, Tetrahedron Lett. 46 (2005) 987–990.
[13] Y.R. Lee, J.H. Choi, S.H. Yoon, Tetrahedron Lett. 46 (2005) 7539–7543.
[14] Y.-L. Shi, M. Shi, Org. Biomol. Chem. 5 (2007) 1499–1504.
[15] M. Takamura, K. Funabashi, M. Kanai, M. Shibasaki, J. Am. Chem. Soc. 122
(2000) 6327–6328.
The mixture of potassium 2-phenylvinyltrifluoroborate
(210 mg,
1 mmol),
N-(2-formylphenyl)methanesulfonamide
(199 mg, 1 mmol) and dibenzylamine (394 mg, 2 mmol) was
sealed in a 10 mL glass vial equipped with a stirring bar and
flushed with dry nitrogen. 2.5 mL of anhydrous toluene was in-
jected and the resulting suspension was stirred at room tempera-
ture for 5 min. Boron trifluoride–diethyl ether complex
(BF3 Á Et2O; 0.25 mL, 281 mg, ꢀ2 mmol) was then added in one por-
tion. The mixture was stirred at 80 °C for 18 h, cooled and worked
[16] Y.M. Chang, Y.S. Park, S.H. Lee, C.M. Yoon, Tetrahedron Lett. 45 (2004) 9049–
9052.